Literature DB >> 9166710

Effects of inhibin A and activin A during in vitro maturation of bovine oocytes in hormone- and serum-free medium.

A E Stock1, T K Woodruff, L C Smith.   

Abstract

The aim of this study was to investigate whether inhibin A and/or activin A play a role in the acquisition of oocyte competence during the final stages of oogenesis. The particular goal was to establish whether inhibin A and activin A exert development-enhancing effects during in vitro maturation in serum-free media and whether such effects are related to changes in the kinetics of meiotic resumption and/or fertilization rates. Cumulus-oocyte-complexes (COCs) were matured in two control media (Medium 199 [M199] with hormones and serum, hormone-serum control; M199 + 0.6% BSA, BSA-control) and nine treatment media (M199 with 0.6% BSA containing 100, 10, and 1 ng/ml of recombinant human inhibin A, recombinant human activin A, and the combination of the two). Oocytes were fertilized and cultured using standard procedures. Cleavage was assessed at 54 h and blastocyst development at 8 days after in vitro fertilization. Kinetics of oocyte maturation and the fertilization rates were evaluated after fixing and staining (Hoechst 33342) of oocytes at 8, 16, and 22 h after onset of in vitro maturation or of presumptive zygotes at 12 h after in vitro fertilization, respectively. Although there was no effect on cleavage rates, inhibin A and activin A significantly enhanced postcleavage development at concentrations of 10 ng/ml (57.7 +/- 7.5% and 56.6 +/- 11.7%, respectively) and 100 ng/ml (50.6 +/- 18.6% and 56.4 +/- 4.0%, respectively) compared to that in the BSA-control group (24.6 +/- 3.2%). Whereas inhibin A- and activin A-treated oocytes showed development-enhancing effects similar to those in the hormone-serum controls, these groups differed with regard to the kinetics of meiotic resumption. Likewise, the enhanced development of the hormone-serum control and the inhibin A/activin A-treated oocytes was not related to increased fertilization rates relative to the BSA-control. These results suggest that inhibin A and activin A may play important roles during the final stages of oogenesis and that recombinant inhibins and activins are useful compounds for the development of a serum-free culture system for in vitro maturation of oocytes from cattle and possibly other mammalian species.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166710     DOI: 10.1095/biolreprod56.6.1559

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

Review 1.  Structural and functional changes linked to, and factors promoting, cytoplasmic maturation in mammalian oocytes.

Authors:  Masayasu Yamada; Yuuki Isaji
Journal:  Reprod Med Biol       Date:  2011-03-17

2.  The effects of macromolecular and serum supplements and oxygen tension during bovine in vitro procedures on kinetics of oocyte maturation and embryo development.

Authors:  Gisele Zoccal Mingoti; Viviane Sggobi Dias Caiado Castro; Simone Cristina Méo; Letícia Siqueira Sá Barretto; Joaquim Mansano Garcia
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-03-18       Impact factor: 2.416

3.  Oocyte morphology and early zygote cleavage does not appear to be related to intrafollicular concentrations of inhibin-A or -B.

Authors:  J Li; S Cooke; J P Tyler; M J Bentley; L Kime; G L Driscoll
Journal:  J Assist Reprod Genet       Date:  2000-09       Impact factor: 3.412

4.  Growth of mouse oocytes to maturity from premeiotic germ cells in vitro.

Authors:  Zhi-Peng Zhang; Gui-Jin Liang; Xi-Feng Zhang; Guo-Liang Zhang; Hu-He Chao; Lan Li; Xiao-Feng Sun; Ling-Jiang Min; Qing-Jie Pan; Qing-Hua Shi; Qing-Yuan Sun; Massimo De Felici; Wei Shen
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

5.  Role of inhibin and activin in the modulation of gonadotropin- and steroid-induced oocyte maturation in the teleost Fundulus heteroclitus.

Authors:  Teresa R Petrino; Gesulla Toussaint; Yu-Wai P Lin
Journal:  Reprod Biol Endocrinol       Date:  2007-06-05       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.